Liposomal amphotericin B for mold infections after liver transplant
Part of Digestive system, Infections clinical trials.
This study looks at how safe and effective a medicine called liposomal amphotericin B is for treating mold infections in people who have had a liver transplant. It may help doctors understand better ways to fight these serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have had a liver transplant.
- You have a confirmed or likely mold infection.
- You have already received at least one dose of liposomal amphotericin B or voriconazole.
- You have not had more than 5 days of prior treatment with amphotericin B for a mold infection.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well liposomal amphotericin B works for treating serious fungal infections in people who have had an organ transplant. It aims to understand the treatment's effectiveness and safety in a real-world setting.
This trial looks at how a specific antifungal medicine, called liposomal amphotericin B, given over a longer period, helps prevent serious fungal infections in people undergoing treatment for cancer or receiving a stem cell transplant. It may be an option if you are at high risk for these infections.
This study follows children and teens with blood cancers who got a fungal infection while on preventive antifungal medicine. It looks at how well liposomal amphotericin B (AmBisome) works and how safe it is for them.
This study tests a new antifungal drug (EL219) compared to two standard treatments (liposomal amphotericin B or voriconazole) for people with weakened immune systems who have a suspected or confirmed mold infection. The goal is to see if the new drug works as well or better at treating the infection.
This trial tests whether amphotericin B can treat new fungal infections that develop in people with blood cancers even after they have taken preventive antifungal medicine. It may help patients who have a confirmed or suspected fungal infection while on that prevention.
This study looks at how a medicine called L-AmB (a type of amphotericin B, used to treat fungal infections) works in patients who are on ECMO. The goal is to find the right dose for people in your situation.
Hear when a new Invasive Mold Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.